Drug Profile
Research programme: long-acting interferon beta - OPKO Health
Alternative Names: MOD-9023Latest Information Update: 08 Sep 2017
Price :
$50
*
At a glance
- Originator Modigene
- Developer OPKO Health
- Class Biobetters; Interferons
- Mechanism of Action Immunomodulators; Interferon beta stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Multiple sclerosis